Physician profile
Taylor Klein
NPI 1992382220
$317.61
in general payments reported to CMS, 2019-2025
11 companies · $210 in 2025
The $210 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $21.21 · 2023: $85.93 · 2025: $210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $296.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $296.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $49.57 | 2023-2025 | Enhertu |
| Abbvie INC. | $47.05 | 2023 | |
| Caris Mpi, INC. | $30.76 | 2025 | Mi Cancer Seek |
| Alexion Pharmaceuticals, INC. | $29.03 | 2025 | Ultomiris |
| Incyte Corporation | $27.55 | 2025 | Monjuvi, Zynyz |
| Bayer Healthcare Pharmaceuticals INC. | $27.46 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $26.28 | 2025 | Calquence |
| Merck Sharp & Dohme LLC | $24.45 | 2025 | Keytruda, Keytruda Qlex |
| Organon LLC | $21.21 | 2022 | |
| Taiho Oncology, INC. | $17.39 | 2025 | |
| Csl Behring | $16.86 | 2023 | Kcentra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Klein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.